PLYMOUTH
MEETING, Pa., Feb. 7, 2024
/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company
focused on developing and commercializing DNA medicines to help
treat and protect people from HPV-related diseases, cancer, and
infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO will present
at the Oppenheimer 34th Annual Healthcare Life Sciences
Conference.
Oppenheimer 34th Annual Healthcare Life Sciences
Conference
Date: Wednesday, February
14, 2024
Time: 12:40 PM ET
Format: Fireside Chat
During the conference, Dr. Shea and members of INOVIO's
management team will conduct one-on-one meetings with registered
investors.
A webcast of the presentation will be available on the INOVIO
Investor Relations Events page at
https://ir.inovio.com/events-and-presentations/default.aspx. A
replay of the webcast will be available for 90 days after the date
of the presentation.
About INOVIO
INOVIO is a biotechnology company focused
on developing and commercializing DNA medicines to help treat and
protect people from HPV-related diseases, cancer, and infectious
diseases. INOVIO's technology optimizes the design and delivery of
innovative DNA medicines that teach the body to manufacture its own
disease-fighting tools. For more information, visit
www.inovio.com.
Contacts
Media: Jennie
Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267)
440-4298 thomas.hong@inovio.com
View original
content:https://www.prnewswire.com/news-releases/inovio-to-present-at-the-oppenheimer-34th-annual-healthcare-life-sciences-conference-302056373.html
SOURCE INOVIO Pharmaceuticals, Inc.